An unusual presentation of a sarcoidosis that mimicked lymphatic metastatize non small cell lung carcinoma in positron emission tomography : a case report by Dzemali, Omer et al.
Case report
Open Access
An unusual presentation of a sarcoidosis that mimicked
lymphatic metastatize non small cell lung carcinoma
in positron emission tomography: a case report
Omer Dzemali*, Nestoras Papadopoulos, Farhad Bakhtiary,
Panagiotis Therapidis and Peter Kleine
Address: Department of Thoracic and Cardiovascular Surgery of Johann Wolfgang Goethe University Hospital, Theodor-Stern-Kai 7,
23A, 60590, Frankfurt am Main/Germany
Email: OD* - dzemali@em.uni-frankfurt.de; NP - nestoras.papadopoulos@gmail.com; FB - farhad@bakhtiary.de; PT - p_therapid@yahoo.de;
PK - P.Kleine@em.uni-frankfurt.de
*Corresponding author
Received: 20 June 2009 Accepted: 20 August 2009 Published: 15 September 2009
Cases Journal 2009, 2:6718 doi: 10.4076/1757-1626-2-6718
This article is available from: http://casesjournal.com/casesjournal/article/view/6718
© 2009 Dzemali et al.; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
In the last decade, several sophisticated and accurate imaging methods such as positron emission
tomography have been developed in order to evaluate malignant potential in enlarged mediastinal
lymph nodes. This case illustrates an unusual presentation of sarcoidosis that mimicked lymphatic
metastases of non small cell lung carcinoma. The reported high specificity and sensitivity of positron
emission tomography-Computer Tomography regarding mediastinal staging could lead in same cases
of false positives to a delaying of stage adapted therapy of non small cell lung carcinoma, showing that
despite the recent advances of imaging techniques, such as positron emission tomography-computer
tomography, several limitations of this imaging technique are still existing.
Introduction
Accurate staging of mediastinal and hilar lymph nodes is a
critical factor determining operability in patients with
NSCLC. Positron emission tomography with has recently
been reported to be more effective in detecting tumor
involvement in mediastinal and hilar lymph nodes than
computed tomography. We report about an interesting
case of false-positive PET finding in mediastinal and hilar
lymph node staging.
Case presentation
An 80-year-old man (ethnic origin: German, nationality:
German) with the medical history of Parkinson’s disease
consulted his neurologist because of paresthesia in his
lower extremities. The patient had 40 pack-years smoking
history but had quit 26 years earlier. His medical history
showed mitral valve insufficiency grade 2, hypertension
and hypercholestererolemia. The social history, family
history and review of systems were otherwise unremark-
able. The physical examination revealed a generally light
reduced state of health, normal vital signs, no fever, with
bilaterally clear lung fields and no lymphadenopathy. His
routine lab values, including complete blood count and
chemistries showed elevated creatinine (1.87 mg/dl) and
urea (93 mg/dl) as well as normochromic normocyteric
anaemia. After readjustment of medical therapy, chest
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above-mentioned symptom. Chest X-ray revealed a solid
contrast-enhancing mass in the right upper lobe (RUL).
Based on these finding CT-scan was ordered and demon-
strated a 1.4 × 3.1 cm pulmonary mass in the lateral
segment of the RUL associated with 2.2 cm node in
precarinal and 2.4 cm node paraaortal position (Figure 1).
A flexible bronchoscopy and transbronchial biopsy of a
parabronchial lymph node were performed. The endo-
scopic findings revealed no endobronchial lesion. Micro-
biological cultures of the gained bronchial secretion
showed no evidence of the growth of germs, fungi or
mycobacteria and the pathology report was negative for
malignancy. CT-guided needle biopsy showed also no
evidence of malignant tumour. PET-CT scan was per-
formed to assess mediastinal nodal disease, and showed
high fluorodeoxyglucose (FDG) uptake in the RUL lesion
with maximum standardized uptake value (SUVmax) of
6.9 (Figure 2). Further uptake was detected in precarinal
(SUVmax: 6.4), infracarinal (SUVmax: 6.4) and paraaortal
(SUVmax: 4.0) lymph nodes as well in a lymph node at
the left main bronchus (Figure 3) corresponding to N3
disease. The TNM classification after PET staging was
NSCLC T2 N3 M0 (UICC IIIB). It was decided to proceed
to thoracotomy in order to obtain histological confirma-
tion. A right lateral thoracotomy was performed and
wedge resection of the RUL. The pathologist’s intraopera-
tive examination resulted in NSCLC (squamous cell
carcinoma, T2) in the RUL. Additionally stage adapted
lymph node dissection was performed. Surprisingly
microscopic examination of the resected RUL tissue
revealed except the squamous cell carcinoma signs of
granulomatous inflammation. Numerous epitheloid cell
granulomas were also found in all resected lymph nodes,
which were free of malignancy. In summary, histological
diagnosis was pulmonary sarcoidosis in addition to
NSCLC. Resected margins and pleural surface were free
of malignancy. The following TNM classification arose
from the pathological examination: pT2, pN0, M0, G2, R0.
Postoperative progress was satisfactory and the patient
was discharged 7 days after surgery. Due to the reduced
general state of health, no secondary lobectomy or
adjuvant chemotherapy was indicated.
Figure 1. 1.4 × 3.1 cm pulmonary mass in the lateral segment
of the RUL associated with enlarged mediastinal lymph nodes.
Figure 2. High fluorodeoxyglucose (FDG) uptake in the
RUL lesion with maximum standartized uptake value
(SUVmax) of 6.9.
Figure 3. Further uptake was detected in precarinal
(SUVmax: 6.4), infracarinal (SUVmax: 6.4) and paraaortal
(SUVmax: 4.0) lymph nodes as well in a lymph node at the left
main bronchus (SUVmax: 4,0), correspond to N3 disease.
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In recent years several sophisticated and accurate imaging
methods have been developed in order to evaluate
malignant potential in solitary pulmonary masses asso-
ciated with enlarged mediastinal lymph nodes.
Multiple studies have demonstrated that PET-CT is more
reliable as a single test for predicting malignancy in a
radiologically undifferentiated nodule and in enlarged
mediastinal lymph nodes than CT scan [1-3]. Positron
emission tomography (PET) is a nuclear medicine imaging
technique which takes advantage of the biological activity
of tumour cells. The system detects pairs of gamma rays
emitted indirectly by a positron-emitting radionuclide
(tracer), which is introduced into the body on a
biologically active molecule. Images of tracer concentra-
tion in 3-dimensional space within the body are then
reconstructed by computer analysis. The most commonly
used PET scanning isotope is 18F-FDG (F-fluoro-2-deoxy-
D-Glucose); the concentrations of tracer imaged then give
tissue metabolic activity, in terms of regional glucose
uptake. The concept of emission and transmission
tomography was introduced by David Kuhl and Roy
Edwards in the late 1950s. Their work later led to the
design and construction of several tomographic instru-
ments. In the 1970s, Tatsuo Ido was the first to describe
the synthesis of 18F-FDG.
The reported sensitivity and specificity of PET regarding
mediastinal staging is reported to be 74-84% and 85-89%
respectively with a negative predictive value of 93-95%
[4,5]. Gould and coworkers reported about a sensitivity of
even 100% and a specificity of 78% in particular in
patients with in CT detected enlarged mediastinal lymph
nodes [6]. On the other hand, in up to a quarter of patients
wrongly positive findings may result. Therefore, histolo-
gical confirmation of positive PET staging has to remain
golden standard.
In our case a whole body PET-CT scan was performed to
assess mediastinal nodal disease, and showed high FDG
uptake in precarinal, infracarinal, paraaortal and contral-
ateral left main bronchus lymph nodes corresponding to
N3 disease (T2, N3, M0 / UICC IIIB). Transbronchial
biopsy of a parabronchial lymph nodes and CT-guided
needle biopsy of the pulmonary mass showed no evidence
of malignant tumor. Afterwards we decided to proceed to
thoracotomy in order to assess the high uptake lymph
nodes and lesion in the RUL. The lymph nodes found to
be positive on PET were discovered to be not malignant by
the surgical biopsy. Numerous epitheloid cell granulomas
were found in all resected lymph nodes in accordance with
sarcoidosis. Pathologic staging resulted in significant
downstaging relevant for further therapy, as our patient
based on current ATS guidelines would have been a
candidate for palliative chemotherapy according to PET
staging.
Despite of sarcoidosis, false positive PET results have been
reported to occur, most notably in association with further
active lung diseases such as aspergillomas, active tubercu-
losis and abscesses [7]. Also false negatives are possible for
example in case of carcinoids and in tumour less than
10mm in diameter [7,8].
This case illustrates an unusual presentation of sarcoi-
dosis that mimicked metastatic NSCLC. The high
reported specificity and sensitivity of PET-CT regarding
mediastinal staging could lead in same cases to a delaying
of stage adapted therapy of NSCLC, showing that despite
the recent advances of imaging techniques, such as PET-
CT, several limitations of this imaging technique are still
existing. Histological confirmation of positive PET
findings have to remain the golden standard of NSCLC
staging.
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